Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

PURPOSE: National hepatitis B virus (HBV) screening recommendations for patients with cancer anticipating systemic anticancer therapy range from universal screening to screening based on risk of HBV infection, cancer therapy–specific risk of HBV reactivation, or both. We conducted cost-effectiveness...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JCO Clin Cancer Inform
Huvudupphovsmän: Hwang, Jessica P., Huang, Danmeng, Vierling, John M., Suarez-Almazor, Maria E., Shih, Ya-Chen Tina, Chavez-MacGregor, Mariana, Duan, Zhigang, Giordano, Sharon H., Hershman, Dawn L., Fisch, Michael J., Cantor, Scott B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2019
Ämnen:
Original Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6874018/
https://ncbi.nlm.nih.gov/pubmed/30892921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.18.00097
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk